Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 6

    Zydus gets USFDA tentative nod for  Carbidopa, Levodopa Extended-Release Capsules

    Zydus gets USFDA tentative nod for Carbidopa, Levodopa Extended-Release Capsules

    Medical Dialogues Bureau31 March 2020 1:30 PM IST
    Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Carbidopa and Levodopa Extended-Release Capsules in the strengths of...
    AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

    AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis

    Medical Dialogues Bureau31 March 2020 1:05 PM IST
    Lokelma is a highly selective, oral potassium-removing agent currently approved in the US, EU, Canada, Hong Kong, China, Russia, and Japan for the...
    South Korean coronavirus test kit makers win USFDA pre-approval

    South Korean coronavirus test kit makers win USFDA pre-approval

    Medical Dialogues Bureau30 March 2020 3:46 PM IST
    Seoul: Three Korean coronavirus test-kit makers have won preliminary approval from the U.S. Food and Drug Administration (FDA), paving the way for...
    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Medical Dialogues Bureau30 March 2020 3:04 PM IST
    Coral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
    USIBC urges govt to ease regulatory curbs on APIs, medical devices

    USIBC urges govt to ease regulatory curbs on APIs, medical devices

    Medical Dialogues Bureau30 March 2020 2:58 PM IST
    US-India Business Council has written to Prime Minister Narendra Modi this week to suggested the Centre to "temporarily relax regulatory barriers that...
    Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung

    Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung

    Medical Dialogues Bureau30 March 2020 1:19 PM IST
    Zurich: Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's...
    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Medical Dialogues Bureau30 March 2020 1:18 PM IST
    Mumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Medical Dialogues Bureau29 March 2020 1:32 PM IST
    Hertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
    Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

    Novartis, Life sciences companies commit to fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

    Medical Dialogues Bureau29 March 2020 12:19 PM IST
    Basel: Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and...
    Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

    Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

    Medical Dialogues Bureau29 March 2020 12:15 PM IST
    Venclexta/Venclyxto is being developed by AbbVie and Roche.
    USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

    USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema

    Medical Dialogues Bureau29 March 2020 11:27 AM IST
    AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
    Philips to ramp up production of ventilators in coronavirus fight

    Philips to ramp up production of ventilators in coronavirus fight

    Medical Dialogues Bureau28 March 2020 1:00 PM IST
    Amsterdam: Dutch health technology company Philips is to ramp up production of critical healthcare products to help diagnose and treat patients with...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok